These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 21866091)

  • 1. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
    Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sugars and alcohol: IgA-associated renal diseases in alcoholic cirrhosis.
    Novak J; Julian BA
    Kidney Int; 2011 Dec; 80(12):1252-4. PubMed ID: 22126980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
    Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
    Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
    J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
    Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC
    Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
    Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
    PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine Models of Human IgA Nephropathy.
    Suzuki H; Suzuki Y
    Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC
    Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
    Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
    Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
    BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
    Tamouza H; Chemouny JM; Raskova Kafkova L; Berthelot L; Flamant M; Demion M; Mesnard L; Paubelle E; Walker F; Julian BA; Tissandié E; Tiwari MK; Camara NO; Vrtovsnik F; Benhamou M; Novak J; Monteiro RC; Moura IC
    Kidney Int; 2012 Dec; 82(12):1284-96. PubMed ID: 22951891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.
    van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR
    Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
    BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
    Xu LX; Zhao MH
    Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J
    BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA.
    Grossetête B; Launay P; Lehuen A; Jungers P; Bach JF; Monteiro RC
    Kidney Int; 1998 May; 53(5):1321-35. PubMed ID: 9573548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
    PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy.
    Kim MJ; Schaub S; Molyneux K; Koller MT; Stampf S; Barratt J
    PLoS One; 2016; 11(12):e0166830. PubMed ID: 27930655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J; Tomana M; Matousovic K; Brown R; Hall S; Novak L; Julian BA; Wyatt RJ; Mestecky J
    Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.